Presence of teratoma in the orchiectomy and residual retroperitoneal mass size are known predictors of finding teratoma during post-chemotherapy retroperitoneal lymph node dissections (PC-RPLND). We sought to determine if the percentage of teratoma in the orchiectomy specimen could better stratify the risk of teratoma in the retroperitoneum.